Atom ..now there's where we may see the debate "the high-risk, mostly diabetic primary prevention cohort, which represented approximately 30% of enrolled patients and had a relatively lower observed event rate and experienced a 12% RRR "
From memory that data what not stat sig which I think is your pt of view but Dr Bhatt will argue that it was trending in that direction and if the trial had run longer he believes it would have been stat sig.
He covered this in the Grand Rounds that poster gg linked last wk
News 
Market Data 
Discover 
